Low FT4 Concentrations around the Start of Recombinant Human Growth Hormone Treatment: Predictor of Congenital Structural Hypothalamic-Pituitary Abnormalities?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.